TY - JOUR
T1 - Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy
AU - Tsai, M.
AU - Shiau, Y.
AU - Kao, C.
AU - Shen, Y.
AU - Lin, C.
AU - Lee, C.
PY - 2002
Y1 - 2002
N2 - Purpose: The aim of this study was to evaluate the effectiveness of positron emission tomography (PET) using 18-fluoro-2-deoxyglucose (FDG) to detect recurrent nasopharyngeal carcinomas (NPC) when magnetic resonance imaging (MRI) findings are indeterminate. Patients and methods: After radiotherapy, 28 NPC patients with indeterminate MRI findings were included. MRI, FDG-PET, and biopsy were performed at least 4 months after radiotherapy and within 1 week. The final results were based on histopathologic findings and a clinical follow-up of at least 6 months. Results: For detecting recurrent NPC in indeterminate MRI findings, the sensitivity, specificity and accuracy of FDG-PET were 100.0%, 92.9% and 96.4%, respectively. Conclusions: Based on these results, we can recommend FDG-PET for detecting recurrent NPC when MRI findings are indeterminate.
AB - Purpose: The aim of this study was to evaluate the effectiveness of positron emission tomography (PET) using 18-fluoro-2-deoxyglucose (FDG) to detect recurrent nasopharyngeal carcinomas (NPC) when magnetic resonance imaging (MRI) findings are indeterminate. Patients and methods: After radiotherapy, 28 NPC patients with indeterminate MRI findings were included. MRI, FDG-PET, and biopsy were performed at least 4 months after radiotherapy and within 1 week. The final results were based on histopathologic findings and a clinical follow-up of at least 6 months. Results: For detecting recurrent NPC in indeterminate MRI findings, the sensitivity, specificity and accuracy of FDG-PET were 100.0%, 92.9% and 96.4%, respectively. Conclusions: Based on these results, we can recommend FDG-PET for detecting recurrent NPC when MRI findings are indeterminate.
KW - 18-Fluoro-2-deoxyglucose
KW - Nasopharyngeal carcinomas
KW - Positron emission tomography
UR - http://www.scopus.com/inward/record.url?scp=0036268734&partnerID=8YFLogxK
U2 - 10.1007/s00432-002-0341-6
DO - 10.1007/s00432-002-0341-6
M3 - 文章
C2 - 12029444
AN - SCOPUS:0036268734
SN - 0171-5216
VL - 128
SP - 279
EP - 282
JO - Journal of Cancer Research and Clinical Oncology
JF - Journal of Cancer Research and Clinical Oncology
IS - 5
ER -